Nitrosamines – Risk evaluation outcome: confirmation of no risk identified

Questions and answers on how to correctly fill in this webform

* Mandatory field

Surname and first name

E-mail

Marketing Authorisation Holder name

Marketing Authorisation Holder address

Name of medicine

Type of API

Active pharmaceutical ingredient (API)/intermediate

Marketing Authorisation Number

Procedure Number (DCP, MRP, NAT)

For DCP and MRP use the country code + product counter of maximum 4 numbers, for example BE-106. For national procedure use NAT + product counter of maximum 4 numbers, for example NAT-1125

Upload signed version of the form

One file only.
25 MB limit.
Allowed types: jpg jpeg png txt pdf doc docx ppt pptx xls xlsx rar zip.

Nitrosamines – Risk evaluation outcome: confirmation of no risk identified

* Mandatory field

Privacy